marketcaparena

LPCN

Lipocine Inc.

Company overview

Market capitalization
$17.23M
Employees
14
Latest publication
2026-09-29
About Lipocine Inc.

Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs using its proprietary delivery technology. The company offers TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. It also develops LPCN 1154 (BRLIZIO), an oral neuro-steroid in a Phase 3 pivotal trial for postpartum depression; LPCN 1148, a prodrug of testosterone and testosterone laurate that has completed a Phase 2 trial for the management of decompensated cirrhosis; LPCN 1107, an oral hydroxy progesterone caproate product that has completed a Phase 2 trial for the prevention of recurrent preterm birth; LPCN 1144, an oral prodrug of bioidentical testosterone that has completed a Phase 2 trial for pre-cirrhotic non-alcoholic steatohepatitis; and LPCN 2401, an oral formulation comprising a proprietary anabolic androgen receptor agonist that is in a Phase 2 trial to manage incretin mimetic use in obesity management. In addition, the company is developing LPCN 2201, an oral brexanolone formulation that has completed a Phase 1 trial for major depressive disorders; LPCN 2203, an oral candidate that has completed a Phase 1 trial for management of essential tremor; and LPCN 2101, a neuroactive steroids (NAS) candidate that has completed a Phase 1 trial for drug-resistant epilepsy and women with epilepsy. The company's products focus on neurological and psychiatric central nervous system (CNS) disorders, liver disease, and hormone supplementation in the United States. It has a collaboration with Verity Pharmaceuticals, Inc. to develop and commercialize TLANDO; and TLANDO XR (LPCN 1111), a once-daily oral product candidate that has completed a Phase 2 trial for testosterone replacement therapy. Lipocine Inc. was founded in 1997 and is headquartered in Salt Lake City, Utah.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ1 20242024-03-31 · USDQ4 20232023-12-31 · USDQ3 20232023-09-30 · USD
Total Revenue119,397USD1,145,390USD114,574USD93,864USD3,491,406USD7,617,174USD216,188USD-3,121,996USD
Cost Of Revenue14,814USD14,981USD—15,570USD15,571USD8,512USD8,003USD6,000,794USD
Gross Profit104,583USD1,130,409USD114,574USD93,864USD3,491,406USD7,617,174USD216,188USD-3,121,996USD
Research Development2,749,580USD2,693,910USD2,707,777USD1,061,571USD1,072,872USD2,818,926USD1,674,932USD2,878,798USD
Selling General Administrative1,204,467USD983,390USD767,837USD1,122,477USD873,055USD1,575,719USD1,134,607USD1,042,572USD
Total Operating Expenses3,954,047USD3,646,210USD3,475,614USD2,184,048USD1,945,927USD4,394,645USD2,809,539USD3,921,370USD
Operating Income-3,849,464USD-2,515,801USD-3,361,040USD-2,090,184USD1,545,479USD3,222,529USD-2,593,351USD-7,043,366USD
Interest Income177,570USD145,717USD174,208USD225,511USD233,118USD331,364USD299,379USD317,569USD
Net Interest Income177,570USD145,717USD174,208USD225,511USD233,118USD331,364USD299,379USD317,569USD
Income Before Tax-3,671,894USD-2,370,084USD-3,186,832USD-1,864,673USD1,782,183USD3,513,821USD-2,281,698USD-6,650,970USD
Tax Provision0USD0USD0USD200USD0USD200USD555USD0USD
Net Income-3,671,894USD-2,370,084USD-3,186,832USD-1,864,873USD1,782,183USD3,513,621USD-2,282,253USD-6,650,970USD
Net Income From Continuing Ops-3,671,894USD-2,370,084USD-3,186,832USD-1,864,873USD1,782,183USD3,513,621USD-2,282,253USD-6,650,970USD
Ebit-3,671,894USD-2,370,084USD-3,186,832USD-1,864,673USD1,782,183USD3,513,821USD-2,281,698USD-6,650,970USD
Ebitda-3,657,080USD-2,357,088USD-3,170,724USD-1,849,103USD1,797,754USD3,522,333USD-2,273,695USD-6,643,222USD
Depreciation And Amortization14,814USD12,996USD16,108USD15,570USD15,571USD8,512USD8,003USD7,748USD
Reconciled Depreciation14,814USD14,981USD14,123USD15,570USD15,571USD8,512USD8,003USD7,748USD
Total Other Income Expense Net177,570USD145,717USD174,208USD225,511USD236,704USD291,292USD311,653USD392,396USD
Income Tax Expense—-400USD—200USD—200USD555USD-7,748USD
Interest Expense——————400USD0USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USD
Total Revenue11,198,144USD-2,850,818USD16,140,838USD0USD428,031USD0USD0USD0USD
Cost Of Revenue41,106USD10,175,251USD7,665,559USD9,748,469USD6,464,708USD11,004,281USD8,076,053USD12,580,245USD
Gross Profit11,198,144USD-13,026,069USD8,475,279USD-9,748,469USD428,031USD-11,004,281USD-8,076,053USD-12,580,245USD
Research Development7,351,753USD10,175,251USD7,665,559USD9,748,469USD6,464,708USD11,004,281USD8,076,053USD12,580,245USD
Selling General Administrative5,001,426USD4,904,888USD5,329,776USD8,247,795USD5,289,142USD10,213,695USD10,382,146USD5,801,823USD
Total Operating Expenses12,353,179USD4,904,888USD5,329,776USD17,996,264USD12,087,353USD20,982,160USD18,970,756USD18,382,068USD
Operating Income-1,155,035USD-17,930,957USD3,145,503USD-17,996,264USD-11,325,819USD-21,217,976USD-18,458,199USD-18,382,068USD
Interest Income1,146,902USD1,364,719USD67,700USD75,650USD————
Net Interest Income1,146,902USD1,364,719USD-135,592USD-310,968USD————
Income Before Tax9,033USD-16,351,327USD-634,199USD-20,964,619USD-11,659,322USD-20,982,160USD-18,970,756USD-18,208,178USD
Income Tax Expense681USD755USD200USD200USD700USD700USD752USD200USD
Tax Provision681USD681USD200USD200USD700USD700USD752USD—
Net Income8,352USD-16,352,082USD-634,399USD-20,964,819USD-11,660,022USD-20,982,860USD-18,971,508USD-18,208,378USD
Net Income From Continuing Ops8,352USD-16,299,742USD-634,399USD-20,964,819USD-11,660,022USD-20,982,860USD-18,971,508USD-18,208,378USD
Ebit9,033USD-16,351,327USD-430,907USD-17,996,264USD-11,325,819USD-21,217,976USD-18,970,754USD-18,382,068USD
Ebitda50,139USD-16,322,666USD-430,527USD-17,992,710USD-11,307,224USD-21,189,606USD-18,938,794USD-18,355,347USD
Depreciation And Amortization41,106USD28,661USD380USD3,554USD18,595USD28,370USD31,960USD26,721USD
Reconciled Depreciation41,106USD23,236USD380USD3,554USD18,595USD28,370USD——
Total Other Income Expense Net1,164,068USD1,579,630USD-3,779,702USD-2,968,355USD-333,503USD235,816USD216,078USD173,890USD
Unclassified Operating Expenses—-10,175,251USD-7,665,559USD—————
Interest Expense—0USD203,292USD386,618USD0USD0USD0USD0USD
Non Operating Income Net Other——-3,779,702USD-2,968,355USD-333,503USD———
Net Income Applicable To Common Shares——-634,399USD-20,964,819USD-11,660,022USD-20,982,860USD-18,971,508USD-18,208,378USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Assets25,358,166USD17,005,612USD16,073,167USD18,577,193USD20,499,726USD22,510,501USD20,698,318USD23,032,306USD
Other Current Assets404,452USD1,932,990USD683,797USD362,629USD428,795USD567,915USD588,824USD297,051USD
Total Liab2,527,843USD2,528,196USD1,931,119USD1,448,773USD1,299,649USD1,512,936USD1,581,218USD1,823,943USD
Total Stockholder Equity22,830,323USD14,477,416USD14,142,048USD17,128,420USD19,200,077USD20,997,565USD19,117,100USD21,208,363USD
Other Current Liab645,115USD1,106,783USD912,467USD685,779USD619,410USD921,240USD1,295,871USD1,375,145USD
Common Stock9,076USD8,944USD8,870USD8,865USD8,863USD8,863USD8,863USD8,863USD
Capital Stock9,076USD8,944USD8,870USD8,865USD8,863USD8,863USD8,863USD8,863USD
Retained Earnings-213,068,261USD-209,396,367USD-207,026,283USD-203,839,451USD-201,633,735USD-199,768,862USD-201,551,045USD-199,332,227USD
Cash5,015,608USD5,205,842USD3,901,040USD6,043,980USD3,354,596USD6,205,926USD3,742,941USD5,553,371USD
Cash And Short Term Investments24,729,071USD14,930,387USD15,131,071USD17,935,682USD19,718,646USD21,633,311USD19,823,632USD22,548,795USD
Total Current Assets25,244,934USD16,877,566USD15,930,140USD18,420,043USD20,326,468USD22,321,673USD20,503,938USD22,909,482USD
Total Current Liabilities2,527,843USD2,528,196USD1,931,119USD1,448,773USD1,299,649USD1,512,936USD1,581,218USD1,823,943USD
Current Deferred Revenue320,000USD320,000USD320,000USD320,000USD320,000USD320,000USD——
Net Debt-5,015,608USD-4,756,251USD-3,743,840USD-6,043,980USD-3,354,596USD-6,205,926USD-3,742,941USD-5,553,371USD
Short Term Investments19,713,463USD9,724,545USD11,230,031USD11,891,702USD16,364,050USD15,427,385USD16,080,691USD16,995,424USD
Net Receivables111,411USD14,189USD115,272USD121,732USD179,027USD120,447USD91,482USD63,636USD
Accounts Payable1,562,728USD971,822USD861,452USD442,994USD360,239USD271,696USD285,347USD448,798USD
Property Plant Equipment Net89,479USD104,293USD119,274USD133,397USD149,505USD165,075USD170,627USD99,071USD
Property Plant Equipment Gross1,388,372USD1,388,372USD1,388,372USD1,388,372USD1,388,372USD1,388,372USD1,378,353USD1,298,286USD
Accumulated Other Comprehensive Income-7,194USD4,445USD4,627USD-1,243USD5,521USD9,138USD9,942USD-9,719USD
Common Stock Shares Outstanding6,795,000shares5,708,238shares5,413,149shares5,351,957shares5,348,557shares5,422,604shares5,347,940shares5,343,922shares
Non Current Assets Total113,232USD128,046USD143,027USD157,150USD173,258USD188,828USD194,380USD122,824USD
Non Current Liabilities Total0USD0USD0USD0USD0USD0USD0USD0USD
Non Currrent Assets Other23,753USD23,753USD23,753USD23,753USD23,753USD23,753USD23,753USD23,753USD
Net Working Capital22,717,091USD14,349,370USD13,999,021USD16,971,270USD19,026,819USD20,808,737USD18,922,720USD21,085,539USD
Unclassified Equity235,887,626USD223,851,450USD221,145,964USD220,951,384USD220,810,565USD220,739,563USD220,640,477USD220,532,583USD
Short Term Debt—449,591USD157,200USD251,519USD—438,625USD153,365USD—
Short Long Term Debt Total—449,591USD157,200USD251,519USD—438,625USD153,365USD—
Other Assets———————1USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets17,005,612USD22,510,501USD23,001,072USD37,542,922USD52,482,439USD25,352,776USD19,658,280USD20,851,953USD
Other Current Assets1,932,990USD567,915USD773,424USD945,319USD1,514,465USD5,661,258USD545,887USD5,520,113USD
Total Liab2,528,196USD1,512,936USD2,631,629USD1,907,982USD6,912,421USD10,010,857USD13,370,484USD11,418,280USD
Total Stockholder Equity14,477,416USD20,997,565USD20,369,443USD35,634,940USD45,570,018USD15,341,919USD6,287,796USD9,433,673USD
Other Current Liab1,106,783USD921,240USD1,235,652USD1,077,738USD2,016,458USD1,653,178USD449,303USD487,135USD
Common Stock8,944USD8,863USD8,860USD8,852USD8,830USD7,005USD3,766USD2,174USD
Capital Stock8,944USD8,863USD8,860USD8,852USD8,830USD7,005USD3,766USD2,174USD
Retained Earnings-209,396,367USD-199,768,862USD-199,777,214USD-183,425,043USD-172,666,407USD-172,032,008USD-151,067,189USD-138,059,845USD
Cash5,205,842USD6,205,926USD4,771,758USD3,148,496USD2,950,552USD19,217,382USD9,728,523USD8,077,539USD
Cash And Short Term Investments14,930,387USD21,633,311USD22,035,546USD32,529,906USD44,617,957USD19,667,374USD14,068,564USD15,250,576USD
Total Current Assets16,877,566USD22,321,673USD22,861,224USD34,135,080USD46,379,675USD25,329,023USD19,630,973USD20,809,203USD
Total Current Liabilities2,528,196USD1,512,936USD2,631,629USD1,678,126USD5,616,625USD6,583,731USD4,964,877USD4,491,748USD
Current Deferred Revenue320,000USD320,000USD——1,016,458USD———
Net Debt-4,756,251USD-6,205,926USD-4,771,758USD-3,148,496USD-639,727USD-13,626,974USD-2,580,783USD2,182,326USD
Short Term Debt449,591USD438,625USD17,166USD—2,310,825USD3,333,333USD3,333,333USD3,333,333USD
Short Long Term Debt Total449,591USD438,625USD17,166USD—2,310,825USD5,590,408USD7,147,743USD10,259,865USD
Short Term Investments9,724,545USD15,427,385USD17,263,788USD29,381,410USD41,667,405USD449,992USD4,340,041USD7,173,037USD
Net Receivables14,189USD120,447USD52,254USD659,855USD247,253USD391USD16,522USD38,514USD
Accounts Payable971,822USD271,696USD1,395,977USD600,388USD1,289,342USD1,597,220USD1,182,241USD671,280USD
Property Plant Equipment Net104,293USD165,075USD116,095USD131,589USD7,211USD0USD3,554USD18,997USD
Property Plant Equipment Gross1,388,372USD1,388,372USD1,298,286USD1,285,119USD1,151,288USD1,143,697USD3,554USD18,997USD
Accumulated Other Comprehensive Income4,445USD9,138USD7,259USD-20,321USD-18,016USD0USD-38USD-963USD
Common Stock Shares Outstanding5,708,238shares5,422,604shares5,269,671shares5,256,169shares5,154,318shares3,275,768shares1,522,486shares1,256,019shares
Non Current Assets Total128,046USD188,828USD139,848USD3,407,842USD6,102,764USD23,753USD27,307USD42,750USD
Non Current Liabilities Total0USD0USD0USD229,856USD1,295,796USD3,427,126USD8,405,607USD6,926,532USD
Non Currrent Assets Other23,753USD23,753USD23,753USD23,753USD4,073,753USD23,753USD23,753USD23,753USD
Net Working Capital14,349,370USD20,808,737USD20,229,595USD32,456,954USD40,763,050USD18,745,292USD14,666,096USD16,317,455USD
Unclassified Equity223,851,450USD220,739,563USD220,121,678USD219,062,600USD218,277,493USD187,400,629USD157,388,203USD147,530,845USD
Other Liab———229,856USD1,295,796USD1,170,051USD4,591,200USD—
Other Assets———3,276,253USD4,073,753USD23,753USD23,753USD23,753USD
Long Term Investments———0USD2,021,800USD0USD——
Inventory———1USD-41,914,658USD5,000,000USD5,000,000USD—
Net Tangible Assets———35,634,940USD45,570,018USD15,341,919USD6,287,796USD9,433,673USD
Short Long Term Debt————2,310,825USD3,333,333USD3,333,333USD3,333,333USD
Treasury Stock————-40,712USD-40,712USD-40,712USD-40,712USD
Non Current Liabilities Other————1,295,796USD———
Unclassified Non Current Assets————-4,073,753USD———
Unclassified Current Liabilities————-3,327,283USD-3,333,333USD-3,333,333USD-3,333,333USD
Unclassified Non Current Liabilities————-1,295,796USD———
Long Term Debt—————2,257,075USD3,814,407USD6,926,532USD
Unclassified Current Assets—————-5,000,000USD——
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income-3,671,894USD-2,370,084USD-3,186,832USD-2,205,716USD-1,864,873USD1,782,183USD-2,218,818USD-3,068,634USD
Depreciation14,814USD14,981USD14,123USD16,108USD15,570USD15,571USD8,511USD8,512USD
Stock Based Compensation65,398USD53,032USD53,256USD65,205USD71,002USD99,086USD107,894USD102,265USD
Other Non Cash Items-96,418USD-66,403USD-33,908USD-34,416USD-58,209USD-122,161USD-306,227USD-111,819USD
Change To Account Receivables928,771USD101,083USD6,460USD57,295USD-58,580USD-28,965USD-27,846USD36,498USD
Change In Working Capital1,430,963USD-551,033USD167,638USD272,585USD-132,747USD-72,752USD-424,262USD571,899USD
Total Cash From Operating Activities-2,257,137USD-2,919,507USD-2,985,723USD-1,886,234USD-1,969,257USD1,701,927USD-2,832,902USD-2,497,777USD
Capital Expenditures-3USD-3USD-3USD-4USD-3USD-10,019USD-80,067USD-3USD
Free Cash Flow-2,257,140USD-2,919,510USD-2,985,720USD-1,886,230USD-1,969,260USD1,691,908USD-2,912,969USD-2,497,780USD
Investments-9,904,139USD1,571,709USD701,449USD4,500,000USD-882,073USD761,058USD1,022,472USD4,752,371USD
Total Cashflows From Investing Activities-9,904,139USD1,571,709USD701,449USD4,500,000USD-882,073USD761,058USD1,022,472USD4,752,371USD
Total Cash From Financing Activities11,971,042USD2,652,600USD141,334USD75,618USD0USD0USD0USD217,440USD
Issuance Of Capital Stock11,964,056USD2,652,600USD141,334USD75,618USD0USD0USD0USD—
Change In Cash-190,234USD1,304,802USD-2,142,940USD2,689,384USD-2,851,330USD2,462,985USD-1,810,430USD2,472,034USD
Begin Period Cash Flow5,205,842USD3,901,040USD6,043,980USD3,354,596USD6,205,926USD3,742,941USD5,553,371USD3,081,337USD
End Period Cash Flow5,015,608USD5,205,842USD3,901,040USD6,043,980USD3,354,596USD6,205,926USD3,742,941USD5,553,371USD
Other Cashflows From Financing Activities—2,652,600USD141,334USD75,618USD——-209,340USD217,440USD
Unclassified Financing Cash Flow—-2,652,600USD——————
Other Cashflows From Investing Activities——————-4USD4,752,371USD
Unclassified Investing Cash Flow———————-4,752,368USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-9,627,505USD8,352USD-16,352,082USD-10,758,636USD-634,399USD-20,964,819USD-13,007,344USD-11,660,022USD
Depreciation60,782USD41,106USD28,661USD9,453USD380USD3,554USD15,443USD18,595USD
Stock Based Compensation242,497USD408,551USD654,438USD636,140USD603,946USD1,373,182USD1,035,834USD1,457,720USD
Other Non Cash Items-192,938USD-715,031USD1,795,464USD-932,146USD53,750USD2,764,106USD-179,497USD259,865USD
Change To Account Receivables106,258USD-68,193USD738,106USD384,898USD-246,862USD16,131USD21,992USD3,304,480USD
Change In Working Capital-243,557USD-964,211USD2,007,528USD-923,630USD-4,594,667USD1,520,879USD469,347USD-1,994,117USD
Total Cash From Operating Activities-9,760,721USD-1,221,233USD-11,865,991USD-11,968,819USD-4,411,303USD-15,303,098USD-11,666,217USD-12,078,825USD
Capital Expenditures-1USD-90,086USD-13,167USD-133,831USD-7,591USD-7,591USD-7,591USD-7,591USD
Free Cash Flow-9,760,720USD-1,311,319USD-11,879,158USD-12,102,650USD-4,418,894USD-15,303,098USD-11,666,217USD-12,078,825USD
Investments5,891,085USD2,446,061USD12,954,380USD14,293,707USD-43,772,806USD3,892,703USD2,998,227USD11,286,281USD
Total Cashflows From Investing Activities5,891,085USD2,446,061USD13,084,686USD14,293,707USD-43,780,397USD3,892,703USD2,998,227USD11,293,281USD
Total Cash From Financing Activities2,869,552USD209,340USD404,567USD-2,126,944USD26,924,870USD20,899,254USD10,318,974USD10,652,334USD
Issuance Of Capital Stock2,869,552USD209,340USD404,567USD-5,130USD30,246,510USD14,657,508USD13,595,953USD652,334USD
Change In Cash-1,000,084USD1,434,168USD1,623,262USD197,944USD-21,266,830USD9,488,859USD1,650,984USD9,866,790USD
Begin Period Cash Flow6,205,926USD4,771,758USD3,148,496USD2,950,552USD24,217,382USD14,728,523USD13,077,539USD3,210,749USD
End Period Cash Flow5,205,842USD6,205,926USD4,771,758USD3,148,496USD2,950,552USD24,217,382USD14,728,523USD13,077,539USD
Other Cashflows From Financing Activities2,869,552USD209,340USD13,084,686USD211,423USD11,693USD7,674,876USD56,355USD10,000,000USD
Unclassified Financing Cash Flow-2,869,552USD—-13,084,686USD—3,394,360USD1,329,492USD—-10,000,000USD
Net Borrowings——0USD-2,316,667USD-3,333,333USD-1,433,130USD-3,333,334USD10,000,000USD
Change To Inventory———-384,898USD246,862USD-16,131USD-21,992USD—
Change To Liabilities———-688,954USD-944,598USD1,620,119USD473,129USD-936,711USD
Dividends Paid———-211,423USD————
Sale Purchase Of Stock———-21,700USD26,852,150USD13,328,016USD13,652,153USD652,334USD
Other Cashflows From Investing Activities———14,293,707USD-43,780,397,000USD3,892,703USD2,998,227USD7,000USD
Unclassified Investing Cash Flow———-14,159,876USD43,780,397,000USD-3,885,112USD-2,990,636USD—
Cash And Cash Equivalents Changes————-21,266,830USD9,488,859USD1,650,984USD9,866,790USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
FY 2025Yearly · 2025-12-31ProductLicense1,500,000USD0001493152-26-009411
FY 2025Yearly · 2025-12-31ProductRoyalty476,677USD0001493152-26-009411
FY 2024Yearly · 2024-12-31ProductLicense10,900,000USD0001493152-26-009411
FY 2024Yearly · 2024-12-31ProductRoyalty298,144USD0001493152-26-009411
FY 2021Yearly · 2021-12-31ProductLicense11,000,000USD0001493152-23-007178
FY 2021Yearly · 2021-12-31ProductMaterials1,035,844USD0001493152-23-007178
FY 2021Yearly · 2021-12-31ProductMinimum Guaranteed Royalties4,050,000USD0001493152-23-007178
FY 2021Yearly · 2021-12-31ProductSales Based Royalties54,994USD0001493152-23-007178

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.